Evotec SE (EVO) Earnings Date & Reports

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EVO is expected to report earnings to fall 67.74% to -3 cents per share on April 17

Q4'24

Est.

$-0.04

Q3'24

Est.

$-0.12

Q2'24

Missed

by $0.26

Q1'24

Est.

$-0.06

Q4'23

Missed

by $0.04

The last earnings report on November 06 showed earnings per share of -11 cents, meeting the estimate of -11 cents. With 75.43K shares outstanding, the current market capitalization sits at 2.77B.

View a ticker or compare two or three

Compare

EVO